Research at the heart of a federal case against the abortion pill has been retracted
The Supreme Court will hear a case against the abortion pill mifepristone, which could have implications for access to the pill in the country.
A scientific paper raising concerns about the safety of mifepristone has been retracted by its publisher, citing a lack of scientific rigor and conflicts of interest. [ more ]
The Biden administration is opposing a lower court's decision to curtail the use of the abortion pill mifepristone, stating it would have disruptive consequences for women and the FDA.
The case represents a challenge to the FDA's power to regulate drugs and comes after the Supreme Court's decision to end federal abortion protections and overturn Roe v. Wade. [ more ]
Supreme Court Will Hear Challenge to Abortion Pill Access
The Supreme Court will decide on the availability of a commonly used abortion pill, which could limit access to medication used in over half of all pregnancy terminations in the US.
The case raises questions about the regulatory authority of the FDA and the role of the Supreme Court in ruling on abortion access even after its conservative majority declared it would leave the issue to the states. [ more ]
Supreme Court to Decide Fate of Access to Abortion Pill Mifepristone
The U.S. Supreme Court is considering the fate of the abortion pill mifepristone in a case that could have significant implications for reproductive healthcare access.
This case could potentially restrict access to medication abortion in the U.S., affecting states where abortion is legal and potentially reversing previous progress in abortion rights. [ more ]